Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 12;9:46. doi: 10.1186/s13756-020-0702-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2020

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — a Count [Log₁₀ (CFU/mL)] of Presumptive Total E. coli (TEc) and Cefotaxime Resistant E. coli (CREc) in summer Influent samples (b) Count [Log₁₀ (CFU/mL)] of other Coliforms and Cefotaxime Resistant Coliforms in summer influent samples. Legend: Inf SR-3 NA = influent sample at sampling occasion 3 without antibiotic, Inf SR-3 A4 = influent sample at sample occasion 3 with 4 mg/L of cefotaxime antibiotic, Inf SR-3 A8 = influent sample 3 with 8 mg/L of cefotaxime antibiotic; Inf SR-2 NA = influent sample at sampling occasion 2 without antibiotic; Inf SR-2 A4 = influent sample at sample occasion 2 with 4 mg/L of cefotaxime antibiotic; Inf SR-2 A8 = influent sample 2 with 8 mg/L of cefotaxime antibiotic; Inf SR-1 NA = influent sample at sampling occasion 1 without antibiotic; Inf SR-1 A4 = influent sample at sample occasion 1 with 4 mg/L of cefotaxime antibiotic; Inf SR-1 A8 = influent sample 1 with 8 mg/L of cefotaxime antibiotic. Figure 1: c Count [Log₁₀ (CFU/mL)] of Presumptive Total E. coli (TEc) and Cefotaxime Resistant E. coli (CREc) in Winter Influent samples (d) Count [Log₁₀ (CFU/mL)] of other Coliforms and Cefotaxime Resistant Coliforms in Winter Influent samples. e Count [Log₁₀ (CFU/mL)] of E. coli and other coliforms in effluent samples. Legend: Inf SR-4 NA = influent sample at sampling occasion 4 without antibiotic, Inf SR-4 A4 = influent sample at sample occasion 4 with 4 mg/L of cefotaxime antibiotic; Inf SR-4A8 = influent sample during sample occasion 4 with 8 mg/L of cefotaxime antibiotic; Inf SR-4 NA = influent sample at sampling occasion 4 without antibiotic; Inf SR-5 A4 = influent sample at sample occasion 5 with 4 mg/L of cefotaxime antibiotic; Inf SR-5 A8 = influent sample during sample occasion 5 with 8 mg/L of cefotaxime antibiotic; Eff SR-1 NA = effluent sample occasion 1 for E. coli without antibiotic supplementation; Eff SR-2 NA = effluent sample occasion 2 for E. coli without antibiotic supplementation; Eff SR-3 NA = effluent sample occasion 3 for E. coli without antibiotic supplementation; Eff SR-1 O-NA = effluent sample occasion 1 for other coliforms without antibiotic supplementation etc.